Trial intelligence / Profile preview

PRP Combined With huMSCs for Stage 3 and 4 Pressure Injuries

NCT06302582Phase 2Recruiting

Sponsor
Liaocheng City People's Hospital
Start
Feb 2024
Primary completion
Nov 2024
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of human umbilical cord mesenchymal stem cells in pressure injury, sponsored by Liaocheng City People's Hospital. Started Feb 2024; status: recruiting.

02

Drugs

human umbilical cord mesenchymal stem cells
03

Conditions

pressure injury

Beyond the preview

Go deeper on NCT06302582.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06302582.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call